Axsome Therapeutics AXSM
NASDAQ AXSM
$184.39 -1.75 (-0.94%)
At close: Sep 30, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) EV to EBIT (2015 - 2018)

Updated

Axsome Therapeutics' (AXSM) EV to EBIT came in at 2.92 for Q1 2018, up 174.4% from 1.06 a year earlier but down 27.1% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) EV to EBIT (2015 - 2018) Analysis & Trends

For the trailing twelve months through Mar 31, 2018, EV to EBIT at Axsome Therapeutics was -5.49.

  • Quarterly EV to EBIT has run from a low of 1.06 in Q1 2017 to a high of 9.17 in Q1 2016 over five years.
  • On a year-over-year basis, EV to EBIT increased in two of the last six quarters, with an average decline of 3.9%.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 4.00 (Q4 2017), 3.52 (Q3 2017) and 3.14 (Q2 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Axsome Therapeutics 9.74 Bn 8.46 Bn 204.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 2.92
Dec 31, 2017 4.00
Sep 30, 2017 3.52
Jun 30, 2017 3.14
Mar 31, 2017 1.06
Dec 31, 2016 3.37
Sep 30, 2016 5.07
Jun 30, 2016 5.91
Mar 31, 2016 9.17
Dec 31, 2015 6.82
API Access

Axsome Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AXSM&period=max&api_key=YOUR_API_KEY